Outcome of Injection Sclerotherapy With Doxycycline in Lymphatic, and Veno-lymphatic Malformation in Children: A Single Centre Experience
Topic overview
This study evaluates doxycycline sclerotherapy outcomes for treating congenital lymphatic and veno-lymphatic malformations in pediatric patients at a single institution. The research examines intralesional sclerotherapy as an alternative treatment approach for these slow-flow vascular anomalies in children.
Key takeaways
- Doxycycline sclerotherapy is an effective alternative treatment for lymphatic and veno-lymphatic malformations in pediatric patients.
- Intralesional sclerotherapy targets congenital slow-flow vascular malformations without requiring surgical excision.
- Single-center experience demonstrates feasibility of doxycycline as a sclerosing agent for LMs and VLMs in children.
- Treatment approach offers minimally invasive option for managing complex pediatric vascular anomalies.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Outcome of Injection Sclerotherapy With Doxycycline in Lymphatic, and Veno-lymphatic Malformation in Children: A Single Centre Experience. GlobalCastMD Medical Library. 2024-11-04. https://dev.library.globalcastmd.com/article/9383?via_space=staycurrentmd
Comments